Breaking News
August 15, 2018 - College students may experience pressures from secondary exposure to opioid abuse
August 15, 2018 - Powerful new microscope reveals inner workings of human cells with unprecedented clarity
August 15, 2018 - Married people who fight nastily more likely to suffer from leaky guts, study suggests
August 15, 2018 - Working Out After Baby – Drugs.com MedNews
August 15, 2018 - Rheumatoid Factor (RF) Test: MedlinePlus Lab Test Information
August 15, 2018 - ADHD linked to an increased risk of injury in children, study finds
August 15, 2018 - UIC researchers receive NIH funding to develop a better way to regenerate bone or tissues
August 15, 2018 - Study reveals how immune cells in the brain influence sexual behavior
August 15, 2018 - Researchers move closer to finding potential soft spot in drug-resistant tuberculosis
August 15, 2018 - Real-time dynamic monitoring of cell’s nucleus for effective cancer screening
August 15, 2018 - Lower rates of Medicare preventive care visits found in racial, ethnic minority older adults
August 15, 2018 - Scientists identify stress hormone as key factor in failure of immune system to inhibit leukemia
August 15, 2018 - Cytoplan introduces three new nutritional supplements
August 15, 2018 - Effective hemorrhage control critical for survival after motorsport accidents
August 15, 2018 - Sygnature Discovery announces ambitious expansion plan with addition of Alderley Park facility
August 15, 2018 - Dietary carbohydrates could lead to osteoarthritis, new study finds
August 15, 2018 - Male tobacco smokers have decreased number of cannabinoid CB1 receptors, study reveals
August 15, 2018 - Scientists explore ways for drug therapies to reach deadly brain tumors
August 15, 2018 - Rethinking fundamental rule of stroke care: ‘Time is brain!’
August 15, 2018 - Scientists reveal role of ‘junk DNA’ in cancer dissemination
August 15, 2018 - Google’s DeepMind AI could soon be diagnosing eye conditions
August 15, 2018 - Scientists trick the brain to embody the prosthetic limb
August 15, 2018 - Researchers focus on uncoupling obesity from diabetes
August 15, 2018 - A class of proteins shown to be effective in reducing drug-seeking behaviors
August 15, 2018 - FundamentalVR launches first-of-its-kind SaaS software platform for surgical simulation
August 15, 2018 - Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD
August 15, 2018 - Rheumatoid arthritis in pregnancy associated with low birth weight and premature birth
August 15, 2018 - Study may help increase effectiveness of antibiotics against drug-resistant bacteria
August 15, 2018 - Analyzing resident-to-resident incidents in dementia may hold the key to reducing future fatalities
August 15, 2018 - Robotic walking frame aims to help maintain mobility of older adults
August 15, 2018 - Simple intervention during routine care reduces alcohol consumption in men with HIV
August 15, 2018 - Genetics Home Reference: gout
August 15, 2018 - Scientists ID genesis of disease, focus efforts on shape-shifting tau
August 15, 2018 - OncoThira and NDSU enter into license agreement to develop, market cancer compounds
August 15, 2018 - Scientists unravel the mystery behind ovarian cancer with high-grade serous carcinoma
August 15, 2018 - Common signs that indicate vision problems in children
August 15, 2018 - Removing the cancer label – overhaul in cancer classification proposed
August 15, 2018 - Prams may expose babies and toddlers to more air pollution finds study
August 15, 2018 - Duke researchers track missing T-cells in glioblastoma patients
August 15, 2018 - Cardiac Profiles Up With Exercise, Less Sitting in Early Old Age
August 15, 2018 - Precision medicine offers a glimmer of hope for Alzheimer’s disease
August 15, 2018 - Immunovia’s new blood-based testing platform accurately detects non-small cell lung cancer
August 15, 2018 - New method provides a ‘big picture’ of genetic influences on traits and diseases
August 15, 2018 - Early Onset Type 1 Diabetes Linked to Heart Disease, Shorter Life
August 14, 2018 - SMURF1 provides targeted approach to preventing cocaine addiction relapse
August 14, 2018 - Genetic testing pushed for hereditary high cholesterol disease
August 14, 2018 - Researchers discover new genes involved in Alzheimer’s Disease
August 14, 2018 - Medicare to overhaul ACOs but critics fear fewer participants
August 14, 2018 - Adolescent health projects receive meager percentage of global funding, study finds
August 14, 2018 - University Hospitals Seidman Cancer Center launches new CAR-T therapy trial
August 14, 2018 - In the addiction battle, is forced rehab the solution?
August 14, 2018 - Busting myths about milk – Scope
August 14, 2018 - Platelet-rich plasma does not enhance cartilage formation capabilities of stem cells
August 14, 2018 - Wearable devices and ‘mhealth’ technology emerge as promising tools for better health
August 14, 2018 - Johns Hopkins expert panel develops first set of operation-specific opioid prescribing guidelines
August 14, 2018 - Clinical study suggests new treatment direction for head and neck cancer in heavy smokers
August 14, 2018 - Phase 2 Clinical Data Published Showing Summit’s Ridinilazole Preserved Gut Microbiome of Patients with CDI
August 14, 2018 - Cardiac progenitor cells undergo a cell fate switch to build coronary arteries
August 14, 2018 - Study identifies potential guidance to treat gastric cancer patients
August 14, 2018 - Revealed: The molecular mechanism underlying hypertrophic cardiomyopathy, or “workaholic heart”
August 14, 2018 - Diabetes epidemic in Guatemala driven by aging, not obesity
August 14, 2018 - New technology shows potential to streamline the analysis of proteins
August 14, 2018 - Rethinking the stroke rule ‘time is brain’
August 14, 2018 - Incidence of coronary artery compression in children may be more common than previously thought
August 14, 2018 - Study helps to better understand disease caused by Alpha-1 antitrypsin deficiency
August 14, 2018 - AI platform identifies acute neurological illnesses faster than human diagnosis
August 14, 2018 - American College of Rheumatology receives grants to support development of lupus clinical trials
August 14, 2018 - New study explains why women get more migraines than men
August 14, 2018 - American Heart Association Urges Screen Time Limits for Youth
August 14, 2018 - Brief interventions during routine care reduce alcohol use among men with HIV
August 14, 2018 - New genome analysis could identify people at higher risk of common deadly diseases
August 14, 2018 - NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease
August 14, 2018 - Daicel supplies free nanodiamond samples to international researchers
August 14, 2018 - Switching anti-psychotic drugs in first-episode schizophrenia patients does not improve clinical outcomes
August 14, 2018 - Study to examine whether modulating gut bacteria can improve cardiac function in heart failure patients
August 14, 2018 - AI technology could hold key to improving health services
August 14, 2018 - One out of two children not getting enough nutrients needed for their health
August 14, 2018 - Mono-antiplatelet therapy after aortic heart valve replacements may work as well as two drugs
August 14, 2018 - Aid-in-dying patient chooses his last day
August 14, 2018 - Exercise Really Can Chase Away the Blues, to a Point
Edixomed develops revolutionary technology for tackling antimicrobial resistance

Edixomed develops revolutionary technology for tackling antimicrobial resistance

image_pdfDownload PDFimage_print

New results announced at the recent Wounds UK conference and Eurobiofilms 2017 congress, have provided the latest evidence that Edixomed, a UK biotechnology company, has developed a revolutionary new technology for tackling the enormous public health challenge of antimicrobial resistance (AMR). Edixomed’s unique technology, which can be delivered as a liquid, gel or inhaled spray, rapidly and safely kills bacteria, viruses and fungi, including the hardest-to-treat antibiotic resistant strains.

“‘Super-bugs’, resistant to all currently available antibiotics, are expected to kill 10 million people a year by 2050. The threat is very real but we hope to soon have a viable and innovative solution with which to strike” said Professor Art Tucker, St Bartholomew’s Hospital, London.

Through a novel mode-of-action, Edixomed’s core technology safely harnesses one of the body’s natural defense mechanisms, the nitric oxide cycle, to amplify the body’s own response in fighting infection, improving healing and potentially increasing the activity of any prescribed antibiotic. With decades of research supporting the potential of nitric oxide, Edixomed has developed a unique, safe and versatile system, with broad spectrum antimicrobial activity, and which can be used for a variety of clinical applications.

The latest data demonstrated that Edixomed’s breakthrough has the ability to kill all organisms for several deadly infections, such as MRSA and E. coli. Furthermore, Edixomed’s technology effectively prevented and treated multidrug-resistant bacteria biofilms – the large bacterial colonies with a protective layer which normally prevents the body’s immune system, or antibiotics, from being effective.

“Here we have an innovative technology with multiple forms of delivery and applications. It can be inhaled into the lungs for respiratory conditions, applied to the skin as a gel or liquid, or used as a dressing for infected wounds or pre-surgical protection. With such broad applicability this truly could be the breakthrough we’ve been searching for in the fight against antibiotic resistance,” said Professor Ben Benjamin, Honorary Professor of Medicine of Exeter Medical School.

Edixomed’s nitric oxide technology is also being investigated in the clinic, with the most advanced developments in a UK-based randomized control study assessing safety and effectiveness in diabetic foot ulcers, the leading cause of diabetes related amputations.

Commenting on the substantial impact diabetic foot ulcers have, Dr Paul Chadwick, Clinical Director at the College of Podiatry, said, “treatment of diabetic foot ulcers currently costs the NHS more than £1 billion a year and infected ulcers lead to over 135 amputations per week. Early referral to foot-care services, reducing infection and accelerating healing, could significantly contribute to a reduction in the number of these avoidable amputations.”

There is also a compassionate use evaluation of Edixomed’s nitric oxide technology in Buruli ulcers in a clinic in Ghana. Buruli ulcer is one of the priority diseases recognized by the World Health Organization as a neglected tropical disease and most commonly occurs in children. It is caused by a bacterial infection which can result in serious, chronic wounds, with the potential to cause significant scarring and deformity. Patients currently receive antibiotic therapy but it can be slow to work. An ability to tackle the infection more quickly would be a major breakthrough for these patients.

“We are excited by the results we have seen in the clinic and lab and we are working to maximize the potential benefit to as many patients as possible, and as quickly as possible. Edixomed has developed a completely new, important solution to the problem of antibiotic resistance,” said Professor Chris Wood, Chief Medical Officer, Edixomed.

Source:

https://www.edixomed.com/

Tagged with:

About author

Related Articles